|
GTEX-ZVP2
|
51-60
|
Male
|
GTEX-ZVP2-0426 |
Thyroid gland
|
PAXgene |
1
|
1 piece
|
Acceptable
|
 |
|
GTEX-ZVT2
|
51-60
|
Female
|
GTEX-ZVT2-1126 |
Thyroid gland
|
PAXgene |
0
|
1 pieces
|
Acceptable
|
 |
|
GTEX-ZVT3
|
61-70
|
Female
|
GTEX-ZVT3-0726 |
Thyroid gland
|
PAXgene |
1
|
2 pieces, regressive changes
|
Acceptable
|
 |
|
GTEX-ZVT3
|
61-70
|
Female
|
GTEX-ZVT3-3126 |
Pituitary gland
|
PAXgene |
3
|
1 piece, mainly adenohypophysis; ~5x2.5mm portion of neurohypophysis present, delineated, but all badly autolyzed
|
Acceptable
|
 |
|
GTEX-ZVT4
|
51-60
|
Female
|
GTEX-ZVT4-1226 |
Thyroid gland
|
PAXgene |
2
|
2 pieces, features of goitre, regressive changes
|
Acceptable
|
 |
|
GTEX-ZVZP
|
51-60
|
Male
|
GTEX-ZVZP-1026 |
Thyroid gland
|
PAXgene |
1
|
2 pieces
|
Acceptable
|
 |
|
GTEX-ZVZQ
|
61-70
|
Female
|
GTEX-ZVZQ-0626 |
Thyroid gland
|
PAXgene |
3
|
2 pieces, badly autolyzed
|
Acceptable
|
 |
|
GTEX-ZVZQ
|
61-70
|
Female
|
GTEX-ZVZQ-3026 |
Pituitary gland
|
PAXgene |
3
|
1 piece, ~50% neurohypophysis (delineated)/50% adenohypophysis. ~1.5mm focus of prominent dystrophic calcification at junction of neuro/adenophysis, unknown etiology
|
Acceptable
|
 |
|
GTEX-ZWKS
|
21-40
|
Male
|
GTEX-ZWKS-1026 |
Thyroid gland
|
PAXgene |
1
|
2 pieces, patchy lymphocytic thyroiditis, Hashimoto--type
|
Acceptable
|
 |
|
GTEX-ZWKS
|
21-40
|
Male
|
GTEX-ZWKS-3126 |
Pituitary gland
|
PAXgene |
2
|
1 piece, 80% adenohypophysis/20% neurohypophysis (delineated), moderately-markedly autolyzed
|
Acceptable
|
 |
|
GTEX-ZXES
|
21-40
|
Female
|
GTEX-ZXES-0326 |
Thyroid gland
|
PAXgene |
0
|
2 pieces, larger piece includes ~10% fibrofatty tissue
|
Acceptable
|
 |
|
GTEX-ZXG5
|
61-70
|
Male
|
GTEX-ZXG5-0926 |
Thyroid gland
|
PAXgene |
2
|
2 pieces; some nodularity
|
Acceptable
|
 |
|
GTEX-ZXG5
|
61-70
|
Male
|
GTEX-ZXG5-3126 |
Pituitary gland
|
PAXgene |
1
|
2 pieces; NO Pituitary present: 1 piece is muscle, other is blood vessels
|
Unacceptable
|
 |
|
GTEX-ZY6K
|
41-50
|
Male
|
GTEX-ZY6K-0226 |
Thyroid gland
|
PAXgene |
1
|
2 pieces
|
Acceptable
|
 |
|
GTEX-ZYFC
|
51-60
|
Male
|
GTEX-ZYFC-0926 |
Thyroid gland
|
PAXgene |
2
|
2 pieces, one piece is ~10% fibrovascular and adipose tissue
|
Acceptable
|
 |
|
GTEX-ZYFD
|
51-60
|
Male
|
GTEX-ZYFD-0826 |
Thyroid gland
|
PAXgene |
2
|
2 pieces; nodular
|
Acceptable
|
 |
|
GTEX-ZYFD
|
51-60
|
Male
|
GTEX-ZYFD-3126 |
Pituitary gland
|
PAXgene |
2
|
1 piece
|
Acceptable
|
 |
|
GTEX-ZYFG
|
61-70
|
Female
|
GTEX-ZYFG-0626 |
Thyroid gland
|
PAXgene |
1
|
2 pieces; 2, 1 mm parathyroid nodules in 1 piece [annotated]
|
Acceptable
|
 |
|
GTEX-ZYT6
|
21-40
|
Male
|
GTEX-ZYT6-0426 |
Thyroid gland
|
PAXgene |
2
|
2 pieces, micronodular goiter
|
Acceptable
|
 |
|
GTEX-ZYVF
|
51-60
|
Female
|
GTEX-ZYVF-1126 |
Thyroid gland
|
PAXgene |
1
|
2 pieces, multinodular goiter, adherent 1.5mm fibrovascular fragment on one, delineated
|
Acceptable
|
 |
|
GTEX-ZYW4
|
61-70
|
Male
|
GTEX-ZYW4-1126 |
Thyroid gland
|
PAXgene |
2
|
2 pieces; 1 piece has 2, 7 sqmm fibrovascular and fatty stromal foci [annotated]
|
Acceptable
|
 |
|
GTEX-ZYWO
|
41-50
|
Female
|
GTEX-ZYWO-0726 |
Thyroid gland
|
PAXgene |
0
|
2 pieces, fibrosis and atrophy, smaller piece is ~30% fibrous and vascular tissue
|
Acceptable
|
 |
|
GTEX-ZYY3
|
61-70
|
Female
|
GTEX-ZYY3-1926 |
Thyroid gland
|
PAXgene |
1
|
2 pieces, end-stage Hashimoto thyroiditis, marked regressive changes, mulitple foci adherent fat, several delineated
|
Acceptable
|
 |
|
GTEX-ZYY3
|
61-70
|
Female
|
GTEX-ZYY3-3226 |
Pituitary gland
|
PAXgene |
2
|
1 piece, moderately autolyzed adenohypophysis
|
Acceptable
|
 |
|
GTEX-ZZ64
|
21-40
|
Male
|
GTEX-ZZ64-0126 |
Thyroid gland
|
PAXgene |
0
|
2 pieces
|
Acceptable
|
 |